Taken together, these results are a major reason why many researchers view retatrutide as one of the most promising developments currently being studied in medical weight loss
Obesity and prostate cancer: making sense out of apparently conflicting data
If you plan more than 10 doses from a single vial, consider transferring contents to smaller aliquots immediately after reconstitution
If you are living with type 2 diabetes and wondering whether Wegovy or Ozempic fits better, your clinician will weigh A1C goals, weight, cardiovascular history, side effects, and insurance coverage before recommending one or the otheror sometimes both GLP-1 and other classes together
Other side effects are rare and usually mild when they do occur
Previous diagnoses and medications Out of all 45,326 incident patients included within the entire period, 85.8% had at least one of the selected cardiovascular and metabolic diagnoses recorded in primary care or hospitals during 5 years before being dispensed their first GLP-1 RA, whereas 14.2% had not been given any of these diagnoses (Fig